Feeds › FDA approvals and clearances
FDA approvals and clearances
New drugs and biologics the FDA approved, and the devices it cleared or approved, from openFDA, with the public companies among the applicants.
About this data
- What it is
- The FDA publishes its decisions on drugs and medical devices through openFDA. We list approved drug applications and the changes approved to them, 510(k) clearances of devices and premarket approvals (PMA) of higher-risk devices, and match the applicant to a public company when the name lines up. The page opens on new brand-name drugs and biologics: the first approval of a new drug application (NDA) or biologics license application (BLA).
- Who files it
- The FDA decides; openFDA publishes the FDA's records. The applicant is the company named in the FDA's record for the application.
- How current
- We check openFDA every day. The FDA refreshes its files on its own schedule, and a decision can appear days to weeks after its date, so the latest approvals may show up late.
- Terms
- openFDAopenFDA is the FDA's public data service. It publishes the FDA's own records of drug approvals and device decisions. openFDA asks users not to imply that the FDA endorses their product or service: this site is not endorsed by or affiliated with the FDA.NDA and BLAA new drug application (NDA) asks the FDA to approve a drug made from chemicals. A biologics license application (BLA) asks for a biologic, such as an antibody or a vaccine. The first approval is the original.supplementA later approved change to a drug that is already on the market: a new use, a new dose, a label change or a manufacturing change. Many supplements are minor.generic drugsA generic drug (an ANDA, or abbreviated new drug application) is approved because it matches a drug already on the market. Generics are made by many companies, most of which are not public.510(k)A device maker shows the FDA that its device is substantially equivalent to one already sold. The FDA clears it, which is a lighter review than an approval.PMAPremarket approval: the FDA's strictest review, for higher-risk devices. The maker must show the device is safe and effective.company matchWe match the applicant's name to a public company automatically, and by hand for the large drugmakers. Most applicants, such as generic makers and private device makers, do not match, and a subsidiary or a differently spelled name can be missed.
- Worth knowing
- This is a record of decisions already made. It is not a calendar of coming decisions: a drug under review does not appear, and we show no review dates. openFDA asks users not to imply that the FDA endorses their product or service: this page is not endorsed by or affiliated with the FDA, and the FDA makes no warranty about the data. It is not for medical decisions. Most applicants, such as generic makers and private device makers, do not match a public company, and a subsidiary or a differently spelled name can be missed, so a row with no ticker may still belong to one. A clearance is not an approval, and many approved supplements are minor.
- Not to be confused with
- Clinical trial updates: what sponsors report about their studies, not what the FDA decided.
All of this comes from openFDA, the FDA's public data service. This site is not endorsed by or affiliated with the FDA.
Source and freshness · Information, not investment advice (disclaimer).
FDA decisions per day, last 30 days
Brand-name drugs and biologics, with supplements Device clearances and approvals
By the FDA's decision date. Generic drugs are left out. The FDA's files can lag a decision by days to weeks, so the most recent days fill in later.
Latest FDA decisions
Showing: ticker TNDM · Everything
| Decided | Product | ApplicantWe match the applicant's name to a public company automatically, and by hand for the large drugmakers. Most applicants, such as generic makers and private device makers, do not match, and a subsidiary or a differently spelled name can be missed. | DecisionA new drug application (NDA) asks the FDA to approve a drug made from chemicals. A biologics license application (BLA) asks for a biologic, such as an antibody or a vaccine. The first approval is the original. A device maker shows the FDA that its device is substantially equivalent to one already sold. The FDA clears it, which is a lighter review than an approval. Premarket approval: the FDA's strictest review, for higher-risk devices. The maker must show the device is safe and effective. | FDA page |
|---|---|---|---|---|
| Apr 24, 2026 | Control-IQ+ technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K260429 ↗ |
| Nov 6, 2025 | Tandem Mobi insulin pump with interoperable technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K253074 ↗ |
| Sep 24, 2025 | t:slim X2 insulin pump with interoperable technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K250792 ↗ |
| Aug 6, 2025 | SteadiSet infusion set | TNDM Tandem Diabetes Care | Device clearance (510(k)) Abbreviated | K251854 ↗ |
| May 21, 2025 | Control-IQ+ technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K250798 ↗ |
| Feb 24, 2025 | Control-IQ+ technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K243823 ↗ |
| Jul 26, 2024 | Tandem Mobi Insulin Pump with interoperable technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K241078 ↗ |
| Mar 21, 2024 | Tandem Mobi insulin pump with interoperable technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K240309 ↗ |
| Nov 3, 2023 | Control-IQ Technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K232382 ↗ |
| Nov 3, 2023 | t:slim X2 Insulin Pump with Interoperable Technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K232380 ↗ |
| Oct 5, 2023 | Tandem Mobi insulin pump with interoperable technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Special | K233044 ↗ |
| Jul 10, 2023 | Tandem Mobi Insulin Pump with Interoperable Technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K223213 ↗ |
| Feb 15, 2022 | t:slim X2 Insulin Pump with Interoperable Technology (with… | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K203234 ↗ |
| Jun 16, 2020 | Control-IQ Technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K200467 ↗ |
| Jun 4, 2020 | t:slim X2 Insulin Pump with Interoperable Technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Special | K201214 ↗ |
| Feb 28, 2020 | Basal-IQ Technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K193483 ↗ |
| Dec 13, 2019 | Control-IQ Technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) De Novo | DEN190034 ↗ |
| Feb 14, 2019 | t:slim X2 insulin pump with interoperable technology | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) De Novo | DEN180058 ↗ |
| Nov 29, 2018 | t:slim X2 Insulin Pump with Basal-IQ Technology Automated insulin dosing , threshold suspend | TNDM Tandem Diabetes Care, Inc. | Device approval (PMA), supplement Real-Time Process | P180008 ↗ |
| Nov 29, 2018 | t:slim X2 Insulin Pump with Basal-IQ Technology Automated insulin dosing , threshold suspend | TNDM Tandem Diabetes Care, Inc. | Device approval (PMA), supplement Real-Time Process | P180008 ↗ |
| Nov 29, 2018 | t:slim X2 Insulin Pump with Basal-IQ Technology Automated insulin dosing , threshold suspend | TNDM Tandem Diabetes Care, Inc. | Device approval (PMA), supplement Real-Time Process | P180008 ↗ |
| Jun 21, 2018 | t:slim X2 Insulin Pump with Basal-IQ Technology Automated insulin dosing , threshold suspend | TNDM Tandem Diabetes Care, Inc. | Device approval (PMA) | P180008 ↗ |
| May 2, 2018 | t:slim X2 Insulin Pump with DexcomG5 Mobile CGM System Pump, infusion, insulin, to be used with invasive glucose s… | TNDM Tandem Diabetes Care, Inc. | Device approval (PMA), supplement Real-Time Process | P140015 ↗ |
| Apr 17, 2018 | t:slim G4 Insulin Pump with Dexcom G4 Platinum CGM (t:slim… Pump, infusion, insulin, to be used with invasive glucose s… | TNDM Tandem Diabetes Care, Inc. | Device approval (PMA), supplement Real-Time Process | P140015 ↗ |
| Dec 21, 2017 | t:slim G4 Insulin Pump with Dexcom G4 Platinum CGM Pump, infusion, insulin, to be used with invasive glucose s… | TNDM Tandem Diabetes Care, Inc. | Device approval (PMA), supplement Normal 180 Day Track No User Fee | P140015 ↗ |
| Aug 25, 2017 | t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Pump, infusion, insulin, to be used with invasive glucose s… | TNDM Tandem Diabetes Care, Inc. | Device approval (PMA), supplement Panel Track | P140015 ↗ |
| Mar 20, 2017 | T:SLIM G4 INSULIN PUMP WITH DEXCOM G4 PLATINUM CGM Pump, infusion, insulin, to be used with invasive glucose s… | TNDM Tandem Diabetes Care, Inc. | Device approval (PMA), supplement Real-Time Process | P140015 ↗ |
| Mar 6, 2017 | T:SLIM G4 INSULIN PUMP WITH DEXCOM G4 PLATINUM CGM Pump, infusion, insulin, to be used with invasive glucose s… | TNDM Tandem Diabetes Care, Inc. | Device approval (PMA), supplement Real-Time Process | P140015 ↗ |
| Oct 25, 2016 | t:slim Insulin Delivery System, t:flex Insulin Delivery Sys… | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K162080 ↗ |
| Oct 4, 2016 | T:SLIM G4 INSULIN PUMP WITH DEXCOM G4 PLATINUM CGM Pump, infusion, insulin, to be used with invasive glucose s… | TNDM Tandem Diabetes Care, Inc. | Device approval (PMA), supplement Real-Time Process | P140015 ↗ |
| Oct 4, 2016 | T:SLIM G4 INSULIN PUMP WITH DEXCOM G4 PLATINUM CGM SYSTEM Pump, infusion, insulin, to be used with invasive glucose s… | TNDM Tandem Diabetes Care, Inc. | Device approval (PMA), supplement Real-Time Process | P140015 ↗ |
| Jul 25, 2016 | t:slim Insulin Delivery System | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K160056 ↗ |
| Jul 13, 2016 | t:slim Insulin Delivery System, t:flex Insulin Delivery Sys… | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K160482 ↗ |
| Mar 24, 2016 | T:SLIM G4 INSULIN PUMP WITH DEXCOM G4 PLATINUM CGM Sensor, glucose, invasive | TNDM Tandem Diabetes Care, Inc. | Device approval (PMA), supplement Real-Time Process | P140015 ↗ |
| Sep 8, 2015 | T:SLIM G4 INSULIN PUMP WITH DEXCOM G4 PLATINUM CGM Pump, infusion, insulin, to be used with invasive glucose s… | TNDM Tandem Diabetes Care, Inc. | Device approval (PMA) | P140015 ↗ |
| Jan 9, 2015 | t:flex Insulin Delivery System | TNDM Tandem Diabetes Care, Inc. | Device clearance (510(k)) Traditional | K143189 ↗ |
36 items, most recent first (up to 50). Each row links to the FDA's page for the application, clearance or approval. Updated Nov 15, 2026, 6:50 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates